We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Puretech Health Plc | LSE:PRTC | London | Ordinary Share | GB00BY2Z0H74 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 2.34% | 219.00 | 218.00 | 219.00 | 224.50 | 214.00 | 214.00 | 837,599 | 16:29:47 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Home Health Care Services | 23.75M | -50.35M | -0.1839 | -11.91 | 599.77M |
TIDMPRTC
RNS Number : 9994H
PureTech Health PLC
13 June 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi 1. Identity of the issuer or the underlying issuer of existing PURETECH HEALTH PLC shares to which voting rights are attached: ii ------------------------------------------------------- --------------------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ------------------------------------------------------------------------------------------------------ An acquisition or disposal of voting rights Yes --------------------------------------------------------- ------------------------------------------- An acquisition or disposal of qualifying financial No instruments which may result in the acquisition of shares already issued to which voting rights are attached --------------------------------------------------------- ------------------------------------------- An acquisition or disposal of instruments with No similar economic effect to qualifying financial instruments --------------------------------------------------------- ------------------------------------------- An event changing the breakdown of voting rights No --------------------------------------------------------- ------------------------------------------- Other (please specify): No --------------------------------------------------------- ------------------------------------------- 3. Full name of person(s) subject to the notification Recordati SA Chemical and Pharmaceutical obligation: iii Company --------------------------------------------------- ------------------------------------------------- 4. Full name of shareholder(s) (if different from 3.):iv --------------------------------------------------- ------------------------------------------------- 5. Date of the transaction and date on which the threshold 12 June 2017 is crossed or reached: v --------------------------------------------------- ------------------------------------------------- 6. Date on which issuer notified: 13 June 2017 --------------------------------------------------- ------------------------------------------------- 7. Threshold(s) that is/are crossed or reached: vi, vii Below 3% --------------------------------------------------- ------------------------------------------------- 8. Notified details: ---------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares viii, ix ---------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of shares to the triggering triggering transaction transaction if possible using the ISIN CODE ------------- ----------------------------------- ------------------------------------------------------------------ Number Number Number Number of voting % of voting of Shares of Voting of shares rights rights x Rights ------------- ----------------- ---------------- -------------- ----------------------- ------------------------- Direct Direct Indirect Direct Indirect xi xii ------------- ------------- ------------ -------------- --------- ------------ ------------ ----------- GB00BY2Z0H74 9,554,140 9,554,140 0 0 0 0% 0 ------------- ----------------- ---------------- -------------- --------- ------------ ------------ ----------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Conversion Number of voting % of voting financial date xiii Period xiv rights that rights instrument may be acquired if the instrument is exercised/ converted. ----------------- --------------- -------------------------------- ------------------------- --------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date xvii Conversion rights instrument rights xix, instrument period refers to xx xviii --------------- --------------- -------------- ---------------- ------------------------- ----------------------- Nominal Delta --------------- --------------- -------------- ---------------- ------------------------- ------------ --------- Total (A+B+C) ---------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights ---------------------------------------------------- ---------------------------------------------------------------- 0 0% ---------------------------------------------------- ---------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi ------------------------------------------------------------------------------------------------------ Proxy Voting: ------------------------------------------------------------------------------------------------------ 10. Name of the proxy holder: ----------------------------------------------------------------- ----------------------------------- 11. Number of voting rights proxy holder will cease to hold: ----------------------------------------------------------------- ----------------------------------- 12. Date on which proxy holder will cease to hold voting rights: ----------------------------------------------------------------- ----------------------------------- This transfer of voting rights 13. Additional information: relates to a merger by absorption of Recordati SA Chemical and Pharmaceutical Company into Recordati S.p.A, with Recordati S.p.A as the surviving entity. ----------------------------------------------------------------- ----------------------------------- 14. Contact name: Silvia Signoretti ----------------------------------------------------------------- ----------------------------------- 15. Contact telephone number: +39 02 48787533 ----------------------------------------------------------------- -----------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLFJMFTMBABBPR
(END) Dow Jones Newswires
June 13, 2017 13:01 ET (17:01 GMT)
1 Year Puretech Health Chart |
1 Month Puretech Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions